|
Home Patient Education Organization Consultations Diabetes Hypertension Lipid disorder Thyroid Arthritis Fever Weight Reduction Asthma over view Jaundice Hepatitis A Sleep disorders Cardiac markers CT MRI Xray Discounts Lab tests Free camps For Patients For Doctors Pharma companies For students For schools Life Insurance Alerts Visitor page Donate About us Disclaimer Feed back |
Markers | Indications | Diagnosis acute MI | Prognostic value | Risk unstable angina | Therapy decision | Reperfusion monitoring
The Cardiovascular Challenge
 |
Cardiovascular diseases contribute to about half of all deaths in industrialized countries. Epidemiological studies demonstrated a similar trend in developing countries. |
WHO: Epidemiological Data
 |
About 14 million people die each year worldwide because of cardiovascular diseases. |
 |
About 20% of all deaths worldwide are caused by cardio vascular diseases. |
 |
About 50% of all deaths in industrialized countries are caused by cardiovascular diseases, the most common disease categories are ischemic heart disease, cerebrovas cular disease and hypertension |
 |
The most critical challenge to treating physicians is the differential diagnosis of acute coronary syndromes, including: |
Myocardial infarction (Ml), Unstable angina pectoris, Stable angina pectoris and Minor myocardial damage.
 |
Accurate diagnosis reduces the costs of unnecessary hospital admissions of patients with chest pain. |
 |
Approximately 35 to 70% of the annual admissions to coronary care units in industrialized countries are considered to be unnecessary admissions |
 |
This clinical guide on the use of cardiac markers provides an overview of most recent guidelines as issued by the following international associations: |
WHO (World Health Organization, ACC (American College of Cardiology), AHA (American Heart Association) NACB (U.S. National Academy of Clinical Biochemistry) and ESC (European Society of Cardiology).
|